{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-003568","form_type":"8-K","ticker":"SLSN","cik":"0000883107","company_name":"SOLESENCE, INC.","filed_at":"2022-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.100128+00:00","generated_at":"2026-06-25T21:19:15.909525+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nanophase reports record Q1 revenue of $8.2M, up 15% YoY; guides to >$40M for FY2022","bullets":["Q1 revenue $8.2M vs $7.1M prior year (+15%); Solésence revenue $5.6M (+29% YoY).","Personal Care Ingredients revenue $2.4M (+71%); API sales up 70% YoY.","18 new products shipped in Q1; 30 new hires across manufacturing, supply chain, commercial.","Record monthly revenue of ~$3.8M in March; over 1M finished goods units shipped in Q1.","Management expects 2022 revenue to exceed $40M, dependent on operational improvements."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-003568","json":"https://secwatch.observer/filing/0001171843-22-003568.json","markdown":"https://secwatch.observer/filing/0001171843-22-003568.md","text":"https://secwatch.observer/filing/0001171843-22-003568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883107/000117184322003568/0001171843-22-003568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883107/000117184322003568/f8k_051122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:19:15.909525+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}